Study Exclusion reasons Remarks Reference(s)
Elgazzar, 0 - preprint withdrew on 14 July 2021 due to verifiable concerns (https://grftr.news/why-was-a-major-study-on-ivermectin-for-covid-19-just-retracted/)

10.21203/rs.3.rs-100956/v3

  
NCT04425850 (Caravallo), 2020 non randomized controlled trial

Caravallo HE Journal of Biomedical Research and Clinical Investigation https://doi.org/10.31546/2633-8653.1007

  
Patel, 2020 prospective cohort cancelled by investigator Surgisphere corporation : retracted publication

Patel

 
Morgenstern, 2020 single-arm no control group

Morgenstern J medRxiv https://doi.org/10.1101/2020.10.29.20222505

 
Hazan, 2021 case series no control group

Hazan S et al. medrxiv;2021.07.06.21259924v1 10.1101/2021.07.06.21259924

  
IDEA, 2020 prospective cohort no control group

Carvallo H medRxiv https://doi.org/10.1101/2020.09.10.20191619

  
Chamie-Quintero,, 2020 population based cohort retrospective no control group No statistical analyses just a comparison of death between several peruvian states with or without mass distribution of ivermectin

Chamie-Quintero, J Open Science Foundation

 
Nasir, 2020 non randomized controlled trial no clinically relevant endpoint

Nasir A et al. 10.2139/ssrn.3734478

  
Nasir, 2020 non randomized controlled trial no clinically relevant endpoint

Nasir A et al. 10.2139/ssrn.3734478

  
Elgazzar - prophylaxis, 2020 randomized controlled trial other withdrawal of the publication

Elgazzar A et al. 10.21203/rs.3.rs-100956/v2

Elgazzar A et al. researchsquare 10.21203/rs.3.rs-100956/v1

  
Samaha, 2021 randomized controlled trial other withdrawal of the publication

Samaha AA Viruses 2021 May 26;13(6):989. 10.3390/v13060989

  
Niaee (vs placebo), 2020 randomized controlled trial other On 8 October 2021 and 9 October 2021, two articles were published by subject-matter experts outlining concerns about various aspects of the study and, in particular, calling into question the randomization of participants. The authors and publishing journal have been alerted to these issues, and this note will be updated with any new information related to the publication.

Niaee MS et al. researchsquare 10.21203/rs.3.rs-109670/v1

Niaee MS et al. Asian Pacific Journal of Tropical Medicine 10.4103/1995-7645.318304

  
Cadegiani -Iver, 2020 observational study other unappropriated control group

Cadegiani FA medrxiv https://doi.org/10.1101/2020.10.31.20223883

  
IFORS (Pott-Junior), 2020 randomized controlled trial other The article has been retracted by Toxicology Reports

Pott-Junior H Toxicol Rep 2021;8:505-510. 10.1016/j.toxrep.2021.03.003

  
Elgazzar - treatment, 2020 randomized controlled trial other withdrawal of the publication

Elgazzar A et al. 10.21203/rs.3.rs-100956/v2

  

- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy - Licence Creative Commons